A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Clinical trial NCT00361335 · COMPLETED

Trial details

NCT number: NCT00361335
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-09-01
Primary completion: 2007-12-01
Enrollment: 643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.